Response to: Are there two disjunct episignatures for KMT2B-related disease?
2024

Response to Concerns About KMT2B-Related Disease

Sample size: 8 Commentary Evidence: low

Author Information

Author(s): Monfrini Edoardo, Ciolfi Andrea, Ferilli Marco, Tartaglia Marco, Di Fonzo Alessio

Primary Institution: University of Milan

Conclusion

The authors clarify that their findings do not support the existence of a new disjunct episignature for KMT2B variants linked to adult-onset dystonia.

Supporting Evidence

  • The authors clarify that the variants studied were predicted as benign or had conflicting predictions.
  • The findings highlight a common differential behavior in DNA methylation among the affected individuals.
  • The authors emphasize the need for further confirmatory studies using independent cohorts.

Takeaway

The authors are responding to questions about their research on KMT2B-related disease, explaining that their findings are not what was suggested by a colleague.

Methodology

The authors used DNA methylation profiling to explore the impact of KMT2B variants.

Potential Biases

There is a risk of misinterpretation of variant significance due to the limitations of in silico tools.

Limitations

The study's conclusions are based on a small sample size, which may limit the generalizability of the findings.

Participant Demographics

The study involved eight affected individuals with rare missense KMT2B variants.

Digital Object Identifier (DOI)

10.1093/braincomms/fcae384

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication